TickerFacts.

Acro Biomedical Co., Ltd. (ACBM): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

60.04M
As of 2025-12-31
60.04M
As of 2026-06-30
0.0%
3-year compound annual growth
2015-09-30: 15.72M2016-09-30: 47.16M2017-09-30: 47.66M2018-09-30: 47.76M2019-09-30: 47.76M2019-12-31: 47.76M2020-12-31: 47.76M2021-12-31: 60.04M2022-12-31: 60.04M2023-12-31: 60.04M2024-12-31: 60.04M2025-12-31: 60.04M60.04M
2015-09-30 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3160.04M0.0%2026-02-11, Balance as of period end
2024-12-3160.04M0.0%2026-02-11, Balance as of period end
2023-12-3160.04M0.0%2025-07-24, Balance as of period end
2022-12-3160.04M0.0%2025-07-18, Balance as of period end
2021-12-3160.04Mn/c2023-07-21, Balance as of period end
2020-12-3147.76M0.0%2022-04-15, Balance as of period end
2019-12-3147.76Mn/a2021-04-02, Balance as of period end
2019-09-3047.76M0.0%2020-01-07, Balance as of period end
2018-09-3047.76M+0.2%2020-01-07, Balance as of period end
2017-09-3047.66M+1.1%2018-12-28, Balance as of period end
2016-09-3047.16Mn/c2018-01-16, Balance as of period end
2015-09-3015.72Mn/a2016-12-16, Balance as of period end